Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season

Eurosurveillance

Volumn 16, Issue 20, 2011, Pages

  Adamson, W E ^a   McGregor, E C ^a   Kavanagh, K ^b   McMenamin, J ^c   McDonagh, S ^d   Molyneaux, P J ^e   Templeton, K E ^f   Carman, W F ^a  

^a West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c HEALTH PROTECTION SCOTLAND   (United Kingdom)

^d RAIGMORE HOSPITAL   (United Kingdom)

^e ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^f Edinburgh Specialist Virology Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS A H1N1 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; 2010 H1N1 INFLUENZA; 2011 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; ANTIBODY SPECIFICITY; ARTICLE; CITY; CONTROLLED STUDY; DRUG EXPOSURE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; NONHUMAN; SEASONAL INFLUENZA; SEASONAL VARIATION; SEROPREVALENCE; UNITED KINGDOM; VACCINATION; VIRUS NEUTRALIZATION;

EID: 79957929259     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Adamson WE, Maddi S, Robertson C, McDonagh S, Molyneaux PJ, Templeton KE, et al. 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill. 2010;15(24):pii=19590. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19590
2. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999;37(4):937-43.
3. Adamson WE, Carman WF. Microneutralisation assays for the detection of 2009 pandemic influenza A(H1N1) antibodies: a comparative test of serum and plasma. J Clin Virol. 2010;49(4):303.
4. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375(9720):1100-8.
5. Health Protection Scotland (HPS). Influenza season. Glasgow: HPS. [Accessed 10 May 2011]. Available from: http://www.hps. scot.nhs.uk/resp/influenzaseason.aspx#background
6. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, Andrews N, et al. Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation. PLoS ONE. 2011;6(2): e17074.
7. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One. 5(9): e12562.
8. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza AH1N1 2009 Health Technol Assess. 2010;14(55):115-92.
9. McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill. 2010;15(40):pii=19678. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19678
10. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, Hungnes O. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill. 2010;15(31):pii=19633. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19633
11. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Geneva:WHO. 17 Feb 2011. Available from: http://www.who.int/csr/disease/ influenza/2011_02_recommendation.pdf.